$40 Million

Cytori Therapeutics

At-the-market Offering

Plus Therapeutics Inc (fka Cytori Therapeutics) is a specialty therapeutics company focused on cancer care. It provides nanotechnology platform for reformulating several hydrophilic and lipophilic Active Pharmaceutical Ingredients. The product candidates of the company include Patented DocePlus and Generic Doxo plus.